Op-ed piece from Dr. Andrew Tatarsky,  president of the

New Post Public Reply Private Reply Replies (0) Message Board
bellsandwhistles
Op-ed piece from Dr. Andrew Tatarsky,  president of the Division of Addiction of the New York State Psychological Association and founder and director of the Center for Optimal Living, an addiction treatment and professional training center in New York City. He has specialized in the field of substance use treatment for over 30 years. He slams addictive and abuse-prone Big Pharma drugs.

Medical marijuana is humane
By Dr. Andrew Tatarsky
Tuesday, January 28, 2014

As a psychologist who has specialized in substance use treatment for over 30 years, I have given a lot of thought to medical marijuana. Over the years, I have seen several patients who have used marijuana medicinally but have suffered — from potential criminal prosecution and the shame, stigma and fear that comes from using an illicit substance. Twenty states and D.C. now permit the use of medical marijuana. New York should join them.

I applaud Gov. Andrew Cuomo's recent acknowledgement of cannabis' medical value for some seriously ill people. However, the 1980 Olivieri Law that he is using, through which medical marijuana would be available through 20 hospitals around the state, has significant restrictions, preventing many patients who need the medicine from receiving it.

The Legislature is currently considering the Compassionate Care Act, which would create one of the best-regulated medical marijuana programs in the country. I urge Cuomo to work with the Legislature to enact this comprehensive legislation this session. Many of my colleagues in the addiction and mental health treatment communities support this bill, as reflected in endorsements by the New York State Psychological Association and its Division on Addiction.

Allowing the seriously ill access to safe and legal medical marijuana under their health care provider's supervision is, fundamentally, an issue of compassion and human rights . The medical value of cannabis is no longer a matter of dispute. The efficacy of cannabis for controlling certain conditions and symptoms is well-established in the scientific literature. And, compared to other prescription medications, like widely used opioid pain relievers, medical cannabis is relatively safe, having no known lethal dose and few side effects.

The Compassionate Care Act will ultimately make the job of drug treatment professionals like me easier. The worst dangers associated with medical marijuana come from forcing patients to seek medical marijuana on the illicit market, with potentially devastating consequences — like untested and possibly contaminated product, lifelong criminal records, and shame and stigma from using an illegal substance.

It's time to acknowledge that our current efforts to prohibit marijuana use, by pushing an abstinence-only message and exaggerating the dangers, have failed. Marijuana use by young people can be a problem and should be discouraged, but denying those with debilitating medical conditions access to medical marijuana is not a winning prevention strategy.

When our young people learn that their drug education is filled with misinformation about marijuana, we lose credibility and damage our ability to teach them accurate information about the real dangers of marijuana and other drugs.

We need honest, reality-based drug prevention and treatment programs to reduce the problematic use of marijuana by children and adults alike.

In fact, another reason I support the Compassionate Care Act is because it would generate and earmark substantial funding for such prevention programs, which have unfortunately been devastated by cuts in recent years.

I am not suggesting that medical marijuana is the right choice for everyone. There are risks associated with using it, just as with any medication. Medical marijuana shouldn't be recommended for use in adolescents, unless there is a compelling medical need, and people with particular mental illnesses, especially schizophrenia, should avoid using it.

There is also the risk, in a small percentage of users, of overuse and addiction; those cases should be referred to mental health and substance use treatment professionals for assessment and treatment. But we can best assess our patients and address these risks by having an open and honest dialogue — something nearly impossible for most health care practitioners in New York right now.

Our responsibility as drug treatment providers is to work with our patients to help them create full, meaningful, and healthy lives.

We have long had to deal with helping clients who use potentially dangerous and addictive medications (i.e., from Big Pharma) to treat illnesses, and we do so because no one should have to suffer needlessly.

Medical marijuana is a fundamental matter of compassion, and bringing it into a safe, regulated and de-stigmatizing system will solve far more problems than does our current system of criminalizing our sickest and most vulnerable citizens.
http://www.timesunion.com/opinion/article/Med...182570.php

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Brands Must Choose: Cost or Value Leadership?

Updated Category News Views 6

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

Continue Reading
Subaru, Motorq Offer Hardware-Free Fleet Telematics Insights

Updated Category News Views 6

An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...

Continue Reading
Rise Treatment Center Launches in Vegas for Teens

Updated Category News Views 6

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

Continue Reading
CATL Opens Europe's Largest Battery Service Hub

Updated Category News Views 6

A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...

Continue Reading
Starr Conspiracy Unveils AI Tool for B2B Tech Firms

Updated Category News Views 6

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...

Continue Reading
Unicycive's Legal Turmoil: Opportunity for Investor Action

Updated Category News Views 5

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

Continue Reading
New Podcast by Paralyzed Veterans of America Offers Unique Insights

Updated Category News Views 6

Empowering Veterans Through Storytelling Some stories don't just rattle around in your headphones—they stick with you. The 'Voices of PVA' podcast, launched by Paralyzed Veterans of America, aims to do exactly that. It's not just a podcast; it's a platform where voices of veterans and people with spinal cord injuries like MS and ALS aren't just heard, they're amplified....

Continue Reading
Dr. David Lifschutz Honored for Psychiatry Innovation

Updated Category News Views 7

Recognizing a Legacy in Mental Wellness Under the glare of recognition's spotlight, Dr. David H. Lifschutz steps into an exclusive circle of elite professionals. He's been acknowledged as a Pinnacle Lifetime Member by The Inner Circle for his remarkable contributions to psychiatry and mental health care. This ain't just any pat on the back. It's a badge of honor stitched...

Continue Reading
Lincoln Educational Services Faces Securities Fraud Suit

Updated Category News Views 4

A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...

Continue Reading
illycaffè's B Corp™ Recertification Reflects Bold Commitment

Updated Category News Views 6

illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...

Continue Reading

Top 5 Most Recently Viewed Articles

ProLogium Advances Green Energy with New Gigafactory Permits

Updated Category News Views 323

ProLogium Receives Key Permits for its New Gigafactory ProLogium, recognized as a leader in next-generation lithium ceramic batteries, proudly announces that its Gigafactory in Dunkirk has received critical construction and environmental permits. This significant achievement emphasizes the company's unwavering commitment to promoting clean energy solutions. A Milestone in...

Continue Reading
Zynex Investors Alert: Class Action Lawsuit Opportunity Ahead

Updated Category News Views 98

Zynex, Inc. Investors Should Take Note of Legal Developments Attention investors of Zynex, Inc. (NASDAQ: ZYXI); there is significant news concerning a class action lawsuit that is currently underway. Bronstein, Gewirtz & Grossman, LLC is leading the charge to notify all affected investors about their potential rights in this matter. If you have incurred losses due to your...

Continue Reading
Understanding Your Rights as an Orthofix Investor Amid Lawsuits

Updated Category News Views 89

Overview of the Class Action Lawsuit Against Orthofix Medical Inc. If you’re an investor in Orthofix Medical Inc. (NASDAQ: OFIX), it's important to know about an ongoing class action lawsuit that could affect your investments. The Gross Law Firm has issued a reminder to shareholders that timing is crucial, especially with a deadline for lead plaintiffs coming up. For...

Continue Reading
Explore Nosferatu: The Immersive Horror Experience Soon!

Updated Category News Views 340

Unveiling Nosferatu: The Immersive Experience Cineverse (NASDAQ: CNVS), a rising star in the entertainment industry, is poised to unveil a captivating event that horror enthusiasts won't want to miss. In partnership with Bloody Disgusting, Focus Features, and Thirteenth Floor Entertainment, they announce the eagerly awaited Nosferatu: The Immersive Experience, inspired by...

Continue Reading
Unlocking Potential: Curql Accelerate's Impactful Fintech Program

Updated Category News Views 263

Curql Accelerate: A Unique Opportunity for Fintech Founders Curql Collective is thrilled to announce the opening of applications for its third Curql Accelerate cohort. This initiative is designed specifically for early-stage fintech founders eager to gain invaluable insights, funding, and connections within the credit union industry. Collaborating with Gener8tor, a...

Continue Reading